Xiaoxiao Wu

Anti-CD19 chimeric antigen receptor T-cells induce durable remission in relapsed Philadelphia chromosome-positive ALL with T315I mutation

Xiaodong Yang, A. Sun, Xiaowen Tang, 2019, Leukemia & lymphoma.

Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report

H. Qiu, Ming-Ming Hu, Jian Zhang, 2020, Biomarker Research.

Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature

H. Qiu, Jian Zhang, Weiqing Qian, 2020, OncoTargets and therapy.